LD-2 disclosure · 3rd Quarter - Report
SANOVAS INC.
Client
- Name
- SANOVAS INC.
- Description
- Biotechnology Company
- Location
- California · United States of America
Registrant
- Description
- government relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesDefense
HR.2810/S.1519, National Defense Authorization Act, 2018, any title, all provisions relating to infection control systems.
LobbyistsLETITIA WHITE · mr DAVID FREDERICK KILIAN · CARL KIME · NEELY MARCUS SILBEY · ANNE MARGARET WAKE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Government Issues
Contacted Congressional offices to invite Members of Congress to visit Sanovas' facility in California.
LobbyistsLETITIA WHITE · CARL KIME · NEELY MARCUS SILBEY · ANNE MARGARET WAKE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
HR.3219/S.___, Department of Defense Appropriations Act, 2018, Title VI, all provisions relating to lung injury and infection control systems. HR.3355/S.___, Department of Homeland Security Appropriations Act, 2018, any title, all provisions relating to EB-5 visas.
LobbyistsLETITIA WHITE · mr DAVID FREDERICK KILIAN · CARL KIME · NEELY MARCUS SILBEY · ANNE MARGARET WAKE
TargetedSENATE · HOUSE OF REPRESENTATIVES
